Clinical Trial Update: Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing peginterferon alfa-2b to glycyrrhizin in interferon-treated patients with chronic hepatitis C and F2/F3 liver fibrosis was terminated; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Glycyrrhizin (glycyrrhizin)
• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: TERMINATED | Results posted: 2012-03-06